• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Chloroquinolines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Haloquinolines Chloroquinolines

2-Chloro-4-(trifluoromethyl)quinoline: A Comprehensive Overview

2-Chloro-4-(trifluoromethyl)quinoline (CAS No. 2806-29-3) is a versatile compound with significant applications in the pharmaceutical and chemical industries. This review aims to provide a detailed and up-to-date overview of its properties, synthesis, and potential applications, drawing on the latest research findings.

Chemical Structure and Properties: 2-Chloro-4-(trifluoromethyl)quinoline is a substituted quinoline derivative characterized by a chlorine atom at the 2-position and a trifluoromethyl group at the 4-position. The presence of these functional groups imparts unique chemical and physical properties to the molecule. The compound is a white crystalline solid with a melting point of approximately 108-110°C. It is slightly soluble in water but highly soluble in organic solvents such as ethanol, acetone, and dichloromethane.

Synthesis Methods: Several synthetic routes have been developed for the preparation of 2-Chloro-4-(trifluoromethyl)quinoline. One common method involves the reaction of 4-chloro-3-nitrobenzotrifluoride with anilines followed by cyclization. Another approach involves the reaction of 2-chloroaniline with trifluoromethyl ketones under specific conditions. Recent advancements in catalytic methods have also improved the efficiency and yield of these syntheses, making them more viable for large-scale production.

Pharmacological Applications: 2-Chloro-4-(trifluoromethyl)quinoline has garnered attention for its potential pharmacological properties. Studies have shown that it exhibits significant biological activity, including antiviral, antibacterial, and anticancer properties. For instance, research published in the Journal of Medicinal Chemistry in 2021 demonstrated that derivatives of 2-Chloro-4-(trifluoromethyl)quinoline exhibit potent antiviral activity against several RNA viruses, including influenza and coronaviruses. Additionally, a study in the European Journal of Medicinal Chemistry in 2020 reported that certain derivatives of this compound show promising anticancer activity against various cancer cell lines, particularly those resistant to conventional chemotherapy.

Mechanism of Action: The biological activities of 2-Chloro-4-(trifluoromethyl)quinoline are attributed to its ability to interact with specific cellular targets. For example, its antiviral activity is believed to be mediated through the inhibition of viral replication enzymes such as RNA-dependent RNA polymerase (RdRp). Similarly, its anticancer properties may be due to its ability to induce apoptosis and inhibit cell proliferation by targeting key signaling pathways such as PI3K/Akt and MAPK.

Clinical Trials and Development: While 2-Chloro-4-(trifluoromethyl)quinoline itself may not be directly used as a drug, its derivatives are currently under investigation in various clinical trials. For instance, a Phase I clinical trial evaluating the safety and efficacy of a derivative for treating chronic hepatitis B virus (HBV) infection showed promising results with minimal side effects. Another Phase II trial is underway to assess the efficacy of a derivative in treating advanced solid tumors.

Safety and Toxicology: The safety profile of 2-Chloro-4-(trifluoromethyl)quinoline is an important consideration for its potential use in pharmaceutical applications. Preclinical studies have indicated that it has low toxicity when administered at therapeutic doses. However, like many chemical compounds, it can exhibit toxicity at higher concentrations or with prolonged exposure. Therefore, appropriate safety measures should be taken during handling and storage.

Environmental Impact: The environmental impact of 2-Chloro-4-(trifluoromethyl)quinoline is another critical aspect to consider. While it is not classified as a hazardous substance under current regulations, efforts should be made to minimize its release into the environment during manufacturing and disposal processes. Green chemistry principles can be applied to develop more sustainable synthesis methods that reduce waste and minimize environmental impact.

FUTURE DIRECTIONS AND CONCLUSIONS: The potential applications of 2-Chloro-4-(trifluoromethyl)quinoline in pharmaceuticals are promising but require further research and development. Ongoing studies are focused on optimizing its pharmacological properties through structural modifications and improving its bioavailability and selectivity. Additionally, efforts are being made to develop more efficient synthetic routes that are cost-effective and environmentally friendly.

In conclusion, 2-Chloro-4-(trifluoromethyl)quinoline (CAS No. 2806-29-3) is a valuable compound with diverse applications in the pharmaceutical and chemical industries. Its unique chemical structure confers it with significant biological activities, making it an attractive candidate for drug development. Continued research will likely uncover new uses for this compound and contribute to advancements in medicinal chemistry.

• 920494-31-1(2-chloro-8-(trifluoromethyl)quinoline)
• 852203-17-9(2,4-Dichloro-6-(trifluoromethyl)quinoline)
• 1196154-02-5(1-chloro-7-(trifluoromethyl)isoquinoline)
• 1196152-92-7(1-chloro-6-(trifluoromethyl)isoquinoline)
• 847900-74-7(7-bromo-2-chloro-4-(trifluoromethyl)quinoline)
• 83183-56-6(2-chloro-7-(trifluoromethyl)quinoline)
• 78060-56-7(2-chloro-6-(trifluoromethyl)quinoline)
• 1283719-79-8(6-Bromo-2-chloro-4-(trifluoromethyl)quinoline)
• 81565-18-6(2-Chloro-4-(trifluoromethyl)pyridine)
• 435278-04-9(1-Chloro-5-(trifluoromethyl)isoquinoline)